Cambridge Cognition Holdings Plc (AIM:COG)
London · Delayed Price · Currency is GBP · Price in GBX 34.71
-1.29 (-3.58%)
Jun 17, 2026, 3:16 PM GMT
AIM:COG Market Cap
AIM:COG has a market cap or net worth of 16.76 million as of June 17, 2026. Its market cap has increased by 6.75% in one year.
Market Cap
16.76M
Enterprise Value
16.50M
Revenue
9.40M
Ranking
n/a
PE Ratio
n/a
Stock Price
34.71
Market Cap Chart
Since April 18, 2013, AIM:COG's market cap has increased from 13.12M to 16.76M, an increase of 27.77%. That is a compound annual growth rate of 1.88%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 16, 2026 | 16.76M | 42.97% |
| Dec 31, 2025 | 11.72M | -24.92% |
| Dec 31, 2024 | 15.61M | -2.50% |
| Dec 29, 2023 | 16.01M | -54.81% |
| Dec 30, 2022 | 35.44M | -9.78% |
| Dec 31, 2021 | 39.28M | 88.84% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 208.80B |
| GSK plc | 79.20B |
| Haleon | 29.84B |
| Smith & Nephew | 9.61B |
| SkinBioTherapeutics | 22.03M |
| CelLBxHealth | 20.17M |
| genedrive | 19.27M |
| IXICO | 18.86M |